# Umuzi (Sutherlandia frutescens)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/umuzi
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-19
**Evidence Score:** 6 / 10
**Category:** African
**Also Known As:** Sutherlandia frutescens, Cancer Bush, Balloon Pea, Sutherlandia, Kankerbos, Umnwele, Insiswa, Phetola

## Overview

Sutherlandia frutescens contains flavonoids and triterpene saponins that demonstrate [antioxidant activity](/ingredients/condition/antioxidant) through DPPH radical scavenging mechanisms. The plant shows preliminary anti-cancer potential by disrupting cellular [ATP production](/ingredients/condition/energy) and increasing adenylate kinase release in laboratory studies.

## Health Benefits

• [Antioxidant activity](/ingredients/condition/antioxidant) demonstrated through in vitro DPPH radical scavenging and FRAP assays (preliminary evidence only)
• Anti-cancer potential shown via reduced ATP content and increased adenylate kinase release in cell lines (in vitro evidence only)
• Traditional use for HIV/AIDS symptom management (no clinical trials available)
• Traditional use for diabetes management (no clinical evidence provided)
• General tonic effects reported in traditional medicine systems (no scientific validation available)

## Mechanism of Action

Sutherlandia frutescens exerts [antioxidant](/ingredients/condition/antioxidant) effects through flavonoid compounds that scavenge DPPH radicals and enhance ferric reducing antioxidant power (FRAP). The plant's triterpene saponins appear to disrupt [mitochondrial function](/ingredients/condition/energy) in cancer cells by depleting ATP content and triggering adenylate kinase release, indicating cellular membrane damage. Traditional therapeutic effects may involve [immune system](/ingredients/condition/immune-support) modulation, though specific molecular pathways remain under investigation.

## Clinical Summary

Current evidence for Sutherlandia frutescens consists primarily of in vitro laboratory studies demonstrating [antioxidant activity](/ingredients/condition/antioxidant) through DPPH and FRAP assays. Anti-cancer research is limited to cell line studies showing reduced ATP levels and increased adenylate kinase release, indicating cytotoxic effects. No large-scale human clinical trials have been conducted to validate therapeutic claims. Traditional use for HIV/AIDS symptom management lacks controlled clinical evidence, though the plant remains widely used in African traditional medicine systems.

## Nutritional Profile

Sutherlandia frutescens (Cancer Bush/Umuzi) is primarily used as a medicinal herb rather than a food source, so nutritional data reflects dried leaf/aerial parts used in preparations. Bioactive compounds dominate the profile: L-canavanine (a non-protein amino acid antimetabolite) at approximately 1-7 mg/g dry weight in leaves — this is the primary pharmacologically active constituent but also potentially toxic at high doses; GABA (gamma-aminobutyric acid) at approximately 1-6 mg/g dry weight, contributing to possible anxiolytic effects; pinitol (D-pinitol, a cyclitol sugar) at approximately 5-15 mg/g dry weight, associated with insulin-mimetic and anti-diabetic activity and considered a key active compound. Flavonoids including kaempferol, quercetin, and hyperoside are present at combined concentrations of approximately 10-30 mg/g dry weight (as aglycone equivalents), contributing to [antioxidant activity](/ingredients/condition/antioxidant). Triterpenoid saponins (sutherlandiosides A-D and cycloartane-type glycosides) are present and contribute to [immunomodulatory](/ingredients/condition/immune-support) and anti-cancer properties. Protein content of dried leaf material is approximately 15-20% by dry weight, though bioavailability is limited due to L-canavanine competition with L-arginine in protein synthesis. Crude fiber approximately 20-25% dry weight. Mineral content includes iron (~150-200 mg/kg dry weight), zinc (~20-30 mg/kg), and potassium (~8-12 g/kg). Vitamin C has been reported in fresh material (~50-100 mg/100g fresh weight). Bioavailability note: L-canavanine may interfere with arginine-dependent metabolic pathways, and saponins may reduce absorption of co-administered nutrients. Aqueous extracts (traditional tea preparation) show good solubility of GABA and pinitol but variable extraction of saponins.

## Dosage & Preparation

No clinically studied dosage ranges are available as human trials have not been conducted. Phytochemical studies have standardized extracts to contain sutherlandioside B at 10.1 µg/mg in aqueous preparations. Traditional preparations include infusions, decoctions, or powders from leaves and stems. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Sutherlandia frutescens safety profile in humans remains poorly documented due to limited clinical research. The plant may interact with antiretroviral medications and immunosuppressive drugs given its traditional use in HIV/AIDS management. Pregnancy and breastfeeding safety have not been established through controlled studies. Potential side effects and appropriate dosing ranges require further investigation through human trials.

## Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses for Sutherlandia frutescens were identified in the research dossier. All available evidence comes from in vitro laboratory studies examining [antioxidant](/ingredients/condition/antioxidant) capacity and anticancer effects in cell cultures. The absence of clinical trial data or PubMed PMIDs indicates a significant research gap for this traditional remedy.

## Historical & Cultural Context

Sutherlandia frutescens, known as Umuzi or cancer bush, has been used for centuries in Southern African traditional medicine, particularly among indigenous groups in South Africa. Traditional applications include treatment of cancer, HIV/AIDS symptoms, diabetes, and as a general health tonic. The plant is typically prepared as infusions or decoctions from leaves and stems.

## Synergistic Combinations

Other African botanicals, [antioxidant](/ingredients/condition/antioxidant) herbs, immune-supporting [adaptogen](/ingredients/condition/stress)s, polyphenol-rich plants

## Frequently Asked Questions

### What is the recommended dosage for Sutherlandia frutescens?

No standardized dosage has been established for Sutherlandia frutescens due to lack of clinical trials. Traditional preparations vary widely, and consultation with healthcare providers familiar with African traditional medicine is recommended.

### Can Sutherlandia frutescens interact with HIV medications?

Sutherlandia frutescens may potentially interact with antiretroviral drugs given its traditional use in HIV/AIDS management. The specific interaction mechanisms are not well-studied, so medical supervision is essential when combining with HIV treatments.

### What compounds give Sutherlandia frutescens its antioxidant effects?

Flavonoids and triterpene saponins are the primary bioactive compounds responsible for Sutherlandia frutescens' antioxidant activity. These compounds demonstrate DPPH radical scavenging and ferric reducing antioxidant power in laboratory studies.

### Is Sutherlandia frutescens safe during pregnancy?

Pregnancy safety for Sutherlandia frutescens has not been established through controlled studies. Given the lack of safety data and potential for herb-drug interactions, pregnant women should avoid use without medical supervision.

### How strong is the evidence for Sutherlandia frutescens anti-cancer effects?

Anti-cancer evidence for Sutherlandia frutescens is limited to preliminary in vitro cell line studies showing ATP depletion and cellular damage. No human clinical trials have been conducted to validate these laboratory findings.

### Who should avoid taking Sutherlandia frutescens supplements?

Individuals with autoimmune conditions should exercise caution, as Sutherlandia frutescens may have immune-stimulating properties that could theoretically exacerbate autoimmune responses. People scheduled for surgery should consult healthcare providers before use, as the herb's effects on immune function and potential interactions with anesthesia are not well-documented. Those with known allergies to plants in the Fabaceae family should avoid this ingredient due to cross-reactivity risk.

### What is the difference between Sutherlandia frutescens extract and whole plant preparations?

Standardized extracts of Sutherlandia frutescens concentrate specific compounds and provide consistent dosing, whereas whole plant preparations contain the full spectrum of phytochemicals but with variable potency depending on harvest and processing conditions. Extract forms are typically more convenient for supplementation and allow for controlled clinical studies, while whole plant preparations preserve traditional preparation methods used in South African herbal medicine. The bioavailability and effectiveness of each form have not been directly compared in human trials.

### Does Sutherlandia frutescens have any documented side effects or adverse reactions?

Limited human safety data exists, though traditional use suggests generally good tolerance at typical dosages without major reported adverse effects. Some individuals may experience mild gastrointestinal symptoms such as nausea or stomach upset, particularly at higher doses or on an empty stomach. Long-term safety and potential cumulative effects have not been systematically evaluated in clinical studies.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*